Overview

Toclizumam Versus Dexamethasone in Severe Covid-19 Cases

Status:
Completed
Trial end date:
2020-08-05
Target enrollment:
Participant gender:
Summary
randomized controlled trial comparing survival benefit of Tocilizumab therapy with dexamethasone in patients with severe COVID 19
Phase:
N/A
Details
Lead Sponsor:
South Valley University
Treatments:
Dexamethasone